Maternal Serum VEGF Predicts Abnormally Invasive Placenta Better than NT-proBNP: a Multicenter Case-Control Study

The aim of this study was to test if maternal serum vascular endothelial growth factor (VEGF) or N-terminal pro B-type natriuretic peptide (NT-proBNP) predicts abnormally invasive placenta (AIP) better. Secondary objective was to test whether the serum levels of VEGF and NT-proBNP can predict the de...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwickert, Alexander, Chantraine, Frédéric, Ehrlich, Loreen, Henrich, Wolfgang, Muallem, Mustafa Zelal, Nonnenmacher, Andreas, Petit, Philippe, Weizsäcker, Katharina, Braun, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Placenta: Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808970/
https://www.ncbi.nlm.nih.gov/pubmed/33025531
http://dx.doi.org/10.1007/s43032-020-00319-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808970/
https://www.ncbi.nlm.nih.gov/pubmed/33025531
http://dx.doi.org/10.1007/s43032-020-00319-y

Ejemplares similares